What Is the Optimal Perioperative Treatment for Variant Subtypes of Bladder Cancer?

IF 5.6 2区 医学 Q1 UROLOGY & NEPHROLOGY
Scott M Gilbert
{"title":"What Is the Optimal Perioperative Treatment for Variant Subtypes of Bladder Cancer?","authors":"Scott M Gilbert","doi":"10.1016/j.euf.2025.07.003","DOIUrl":null,"url":null,"abstract":"<p><p>Urothelial carcinoma subtypes are classified according to the 2022 World Health Organization scheme and are generally high-risk cancers that require multidisciplinary evaluation and management whenever possible. Perioperative systemic therapies (neoadjuvant and adjuvant) should be considered for subtypes that are responsive, but some very rare subtypes do not respond well to systemic therapy. Concerted efforts are needed to identify better therapies for these tumors.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology focus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.euf.2025.07.003","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Urothelial carcinoma subtypes are classified according to the 2022 World Health Organization scheme and are generally high-risk cancers that require multidisciplinary evaluation and management whenever possible. Perioperative systemic therapies (neoadjuvant and adjuvant) should be considered for subtypes that are responsive, but some very rare subtypes do not respond well to systemic therapy. Concerted efforts are needed to identify better therapies for these tumors.

不同亚型膀胱癌的最佳围手术期治疗是什么?
尿路上皮癌亚型根据2022年世界卫生组织方案进行分类,通常是高风险癌症,需要尽可能进行多学科评估和管理。对于反应良好的亚型,应考虑围手术期全身治疗(新辅助和辅助),但一些非常罕见的亚型对全身治疗反应不佳。需要共同努力来确定更好的治疗这些肿瘤的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European urology focus
European urology focus Medicine-Urology
CiteScore
10.40
自引率
3.70%
发文量
274
审稿时长
23 days
期刊介绍: European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU). EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信